M Stage Starts "Support System for Balancing Medical Treatment and Work"
M Stage Group will launch a comprehensive Support System for Balancing Medical Treatment and Work on April 1. It offers financial and time-off support, such as 500,000 yen for cancer diagnoses and up to 30 days of treatment leave, anticipating the 2026 legal revision.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 19:00
- 🔍 Collected: March 30, 2026 at 22:56 (3h 56m after Published)
- 🤖 AI Analyzed: April 24, 2026 at 05:37 (582h 41m after Collected)
M Stage Group Inc. (Shinagawa-ku, Tokyo, Group CEO: Yuji Sugita) will launch a comprehensive "Support System for Balancing Medical Treatment and Work" on April 1, restructuring and expanding multi-layered systems to create an environment where employees can continue to work with peace of mind while receiving appropriate medical treatment.
The "Support System for Balancing Medical Treatment and Work" enriches support systems for each phase of prevention, treatment, and balancing. This includes the "Health Promotion Bonus" that subsidizes optional screenings for the three major diseases up to 20,000 yen per year, the "Cancer Diagnosis Condolence Money" that provides 500,000 yen as support for medical and living expenses when diagnosed with cancer, and the "Life Support Leave" that grants up to 30 days a year of leave available in hourly units for the purpose of treating diseases requiring continuous hospital visits. In addition, a Work-Treatment Balance Coordinator is appointed internally to support employees in balancing their medical treatment and work.
## Background and Purpose
Due to the revision of the Comprehensive Labor Policy Promotion Act, starting April 1, 2026, it will become an obligation to make efforts for all companies to support workers with illnesses in balancing their medical treatment and work. Our group, which develops businesses in the medical and healthcare fields, views it as an important issue to embody an environment where working people faced with an illness do not have to give up their careers due to treatment, nor miss appropriate treatment opportunities due to work.
The purpose of this system is to build a clear and comprehensive support structure for balancing treatment and work by reorganizing the various systems for flexible working styles and health management that were previously scattered across our group, aligning them with the specific phase of medical treatment, and further incorporating new systems aimed at prevention, early detection, and financial support.
## Main Initiatives of the "Support System for Balancing Medical Treatment and Work"
### Support for Prevention and Early Detection
- [Revised] Health Promotion Bonus: For non-smoking employees, we will subsidize optional screening costs that contribute to the early detection of the three major diseases (cancer, stroke, myocardial infarction) up to a maximum of 20,000 yen (tax included) per year.
- Smoking Cessation Support: When visiting a smoking cessation clinic, or receiving individual counseling from an in-house public health nurse, we will subsidize the purchase cost of smoking cessation medication up to a maximum of 20,000 yen once a year.
- Health Promotion Achievement Allowance: An annual amount of 30,000 yen will be paid if the paid leave utilization rate of 60% or more, overtime hours within company regulations, non-smoking, no tardiness or absence, and standard BMI value (health checkup results) are achieved over the year.
- [New] Promotion of Secondary Screenings: As a result of health checkups, secondary screenings (re-examination/detailed examination...
The "Support System for Balancing Medical Treatment and Work" enriches support systems for each phase of prevention, treatment, and balancing. This includes the "Health Promotion Bonus" that subsidizes optional screenings for the three major diseases up to 20,000 yen per year, the "Cancer Diagnosis Condolence Money" that provides 500,000 yen as support for medical and living expenses when diagnosed with cancer, and the "Life Support Leave" that grants up to 30 days a year of leave available in hourly units for the purpose of treating diseases requiring continuous hospital visits. In addition, a Work-Treatment Balance Coordinator is appointed internally to support employees in balancing their medical treatment and work.
## Background and Purpose
Due to the revision of the Comprehensive Labor Policy Promotion Act, starting April 1, 2026, it will become an obligation to make efforts for all companies to support workers with illnesses in balancing their medical treatment and work. Our group, which develops businesses in the medical and healthcare fields, views it as an important issue to embody an environment where working people faced with an illness do not have to give up their careers due to treatment, nor miss appropriate treatment opportunities due to work.
The purpose of this system is to build a clear and comprehensive support structure for balancing treatment and work by reorganizing the various systems for flexible working styles and health management that were previously scattered across our group, aligning them with the specific phase of medical treatment, and further incorporating new systems aimed at prevention, early detection, and financial support.
## Main Initiatives of the "Support System for Balancing Medical Treatment and Work"
### Support for Prevention and Early Detection
- [Revised] Health Promotion Bonus: For non-smoking employees, we will subsidize optional screening costs that contribute to the early detection of the three major diseases (cancer, stroke, myocardial infarction) up to a maximum of 20,000 yen (tax included) per year.
- Smoking Cessation Support: When visiting a smoking cessation clinic, or receiving individual counseling from an in-house public health nurse, we will subsidize the purchase cost of smoking cessation medication up to a maximum of 20,000 yen once a year.
- Health Promotion Achievement Allowance: An annual amount of 30,000 yen will be paid if the paid leave utilization rate of 60% or more, overtime hours within company regulations, non-smoking, no tardiness or absence, and standard BMI value (health checkup results) are achieved over the year.
- [New] Promotion of Secondary Screenings: As a result of health checkups, secondary screenings (re-examination/detailed examination...